Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce T Liang

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Drug Development Research|July 8, 2022
Engineering of A<sub>3</sub> Adenosine and P2Y Nucleotide Receptors and Their LigandsKenneth A Jacobson, Hak Sung Kim, Gnana Ravi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 27, 2022
Nexinhib20 Inhibits Neutrophil Adhesion and β<sub>2</sub> Integrin Activation by Antagonizing Rac-1-Guanosine 5'-Triphosphate InteractionWei Liu, Chunxia G Cronin, Ziming Cao, et al.
Experimental and Molecular Pathology|February 10, 2015
Dsp rul: a spontaneous mouse mutation in desmoplakin as a model of Carvajal-Huerta syndromeC Herbert Pratt, Christopher S Potter, Heather Fairfield, et al.
Vaccines|February 28, 2023
SARS-CoV-2 Antibody Dynamics in Healthcare Workers after mRNA VaccinationKevin D Dieckhaus, Min-Jung Kim, Jian-Bing Shen, et al.
Cardiovascular Research|June 14, 2013
CD13 is essential for inflammatory trafficking and infarct healing following permanent coronary artery occlusion in miceFlavia E Pereira, Chunxia Cronin, Mallika Ghosh, et al.
ACS Pharmacology & Translational Science|July 18, 2024
2-Substituted (N)-Methanocarba A<sub>3</sub> Adenosine Receptor Agonists: In Silico, In Vitro, and In Vivo CharacterizationDilip K Tosh, Matteo Pavan, Chunxia Cronin, et al.
Journal of Medicinal Chemistry|April 28, 2006
Orthogonal activation of the reengineered A3 adenosine receptor (neoceptor) using tailored nucleoside agonistsZhan-Guo Gao, Heng T Duong, Tatiana Sonina, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 22, 2010
cPLA2 is protective against COX inhibitor-induced intestinal damageDavid C Montrose, Krishna Kadaveru, Jillian N M Ilsley, et al.
Medrxiv : the Preprint Server for Health Sciences|July 18, 2020
Novel SARS-CoV-2 specific antibody and neutralization assays reveal wide range of humoral immune response during COVID-19Mikail Dogan, Lina Kozhaya, Lindsey Placek, et al.
Cardio-Oncology (London, England)|June 15, 2018
Use of integrated imaging and serum biomarker profiles to identify subclinical dysfunction in pediatric cancer patients treated with anthracyclinesOlga H Toro-Salazar, Ji Hyun Lee, Kia N Zellars, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Drug Development Research|July 8, 2022
Engineering of A<sub>3</sub> Adenosine and P2Y Nucleotide Receptors and Their LigandsKenneth A Jacobson, Hak Sung Kim, Gnana Ravi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 27, 2022
Nexinhib20 Inhibits Neutrophil Adhesion and β<sub>2</sub> Integrin Activation by Antagonizing Rac-1-Guanosine 5'-Triphosphate InteractionWei Liu, Chunxia G Cronin, Ziming Cao, et al.
Experimental and Molecular Pathology|February 10, 2015
Dsp rul: a spontaneous mouse mutation in desmoplakin as a model of Carvajal-Huerta syndromeC Herbert Pratt, Christopher S Potter, Heather Fairfield, et al.
Vaccines|February 28, 2023
SARS-CoV-2 Antibody Dynamics in Healthcare Workers after mRNA VaccinationKevin D Dieckhaus, Min-Jung Kim, Jian-Bing Shen, et al.
Cardiovascular Research|June 14, 2013
CD13 is essential for inflammatory trafficking and infarct healing following permanent coronary artery occlusion in miceFlavia E Pereira, Chunxia Cronin, Mallika Ghosh, et al.
ACS Pharmacology & Translational Science|July 18, 2024
2-Substituted (N)-Methanocarba A<sub>3</sub> Adenosine Receptor Agonists: In Silico, In Vitro, and In Vivo CharacterizationDilip K Tosh, Matteo Pavan, Chunxia Cronin, et al.
Journal of Medicinal Chemistry|April 28, 2006
Orthogonal activation of the reengineered A3 adenosine receptor (neoceptor) using tailored nucleoside agonistsZhan-Guo Gao, Heng T Duong, Tatiana Sonina, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 22, 2010
cPLA2 is protective against COX inhibitor-induced intestinal damageDavid C Montrose, Krishna Kadaveru, Jillian N M Ilsley, et al.
Medrxiv : the Preprint Server for Health Sciences|July 18, 2020
Novel SARS-CoV-2 specific antibody and neutralization assays reveal wide range of humoral immune response during COVID-19Mikail Dogan, Lina Kozhaya, Lindsey Placek, et al.
Cardio-Oncology (London, England)|June 15, 2018
Use of integrated imaging and serum biomarker profiles to identify subclinical dysfunction in pediatric cancer patients treated with anthracyclinesOlga H Toro-Salazar, Ji Hyun Lee, Kia N Zellars, et al.
Pageof 7